polyvinyl alcohol or oily vehicles, and the hypotensive effect of topical timolol alone and together with pilocarpine was investigated in the treatment of acute closed-angle glaucoma in 75 patients (81 eyes). The results showed that there was no marked difference in the hypotensive effect whether pilocarpine was used frequently or in a single dose, in different concentrations, or in different vehicles after acetazolamide. Topical timolol alone was not effective enough to control the intraocular pressure in acute closed-angle glaucoma, but a good hypotensive effect was seen when topical timolol was followed by pilocarpine. It is concluded that 1 drop of pilocarpine 3 hours after intravenous or intramuscular acetazolamide or after topical timolol may be sufficient to terminate an acute attack. Topical timolol may serve as a valuable alternative when systemic medication is contrai ndicated.
The initial treatment of acute closed-angle glaucoma (CAG) is directed towards lowering intraocular pressure (IOP) by medical means to avoid operating upon a congested eye. This is usually achieved with carbonic anhydrase inhibitors, osmotic agents, and pilocarpine. Miotics may be used with frequent instillation, or once 3 or 4 hours after intravenous acetazolamide (Ganias and Mapstone, 1975) . Pilocarpine is usually administered in polyvinyl alcohol (PVA) or methyl cellulose vehicles. Application of pilocarpine in oil produces an increased hypotensive effect in open-angle glaucoma (Saari et al., 1978b) . The effect of pilocarpine in oily drops has not been studied in CAG. A beneficial effect from a pilocarpine-soaked hydrophilic lens in the management of CAG has been reported (Hillman, 1974; Hillman et al., 1975) .
A new beta-adrenergic blocking agent, timolol maleate, lowers the IOP effectively in primary open-angle glaucoma Boger et al., 1978; Airaksinen, 1979) and in secondary glaucoma (Saari et al., 1978a) but not in capsular glaucoma (Kerty and H0rven, 1978; Airaksinen, 1979 the formation of the aqueous humour . Goethals and Missotten (1977) reported 2 patients with CAG who were treated with topical timolol after maximal acetazolamide and pilocarpine therapy. There are no other reports on the hypotensive effect of timolol in CAG.
In this study we examined the hypotensive effect of acetazolamide with pilocarpine, which was used in different concentrations and vehicles and with different instillation frequencies, and of topical timolol alone and together with pilocarpine. In group 5 all cases showed decrease of IOP 3 hours after timolol (Table 5 ) and subsequent pilocarpine caused reduction to normal of IOP in 3 eyes (cases 69 left eye, 71, and 73). Gonioscopic examination was performed for case 73, which revealed an open chamber angle. In case 69 the reduction of IOP was considered sufficient also in the right eye, and both eyes were successfully operated on. In case 70 the IOP was 26 mmHg and in case 72 it was 42 mmHg at 8 hours; in both cases the IOP was 15 mmHg 12 hours later.
Material and methods

Seventy
The 59-year-old woman (case 74) with bilateral CAG had a final IOP of 12 mmHg at 2 hours in both the right eye treated with intensive instillation of 4% pilocarpine and the left eye treated with a pilocarpine presoaked hydrophilic contact lens. In the right eye of the 78-year-old woman (case 75) treated with 1 drop of 4 % pilocarpine 3 hours after acetazolamide the final IOP was 16 mmHg at 8 hours after starting the treatment.
Discussion
The results indicate that frequent instillation of 4% pilocarpine (Table 2) does not have a greater hypotensive effect in CAG than 2 % pilocarpine (Table 1) . Therefore 40% pilocarpine should not be used, because excessive use of pilocarpine may produce toxic side effects (Epstein and Kaufman, 1965) . To diminish the frequency of instillations and the total dose of pilocarpine in the treatment of CAG the use of a pilocarpine-soaked hydrophilic contact lens has been suggested. This method is as effective as intensive medication with 4% pilocarpine (Hillman, 1974) ; we could observe this in 1 patient.
The instillation frequency may also be reduced by oily drops of pilocarpine, which have a strong and long-lasting miotic effect (Borgmann and Wurster, 1973; Saari et al., 1978c; Smith et al., 1978) and may provide a more conventional and less expensive alternative than a pilocarpine-soaked hydrophilic contact lens in the treatment of CAG. In this study I or 2 oily drops of pilocarpine administered after intramuscular acetazolamide had a good hypotensive effect in 9 of 12 eyes. Ganias and Mapstone (1975) observed that 1 drop of pilocarpine 3 hours after intravenous acetazolamide suffices to stop the attack. A similar observation was made in this study when pilocarpine-PVA drops were used.
In CAG miotics will not cause the ischaemic sphincter to react until the IOP is lowered by other means (Rutkowski and Thompson, 1972) . In this study intramuscular or intravenous acetazolamide followed by pilocarpine had a good hypotensive effect in CAG, but additionally given peroral glycerol did not improve the results (Table 1, cases 13-26) .
Topical timolol maleate reduces IOP by suppressing aqueous humour production nearly as effectively as systemic carbonic anhydrase inhibitors (Coakes and Brubaker, 1978) , but in contrast to these and osmotic agents topical timolol has no appreciable side effects. In this study 2 drops of timolol had a good hypotensive effect in 3 cases with CAG, and topical timolol followed 3 hours later by pilocarpine reduced the IOP to normal levels in all cases during an extended observation period.
On the basis of the results of this study and of an earlier report (Ganias and Mapstone, 1975) it is sufficient to treat patients with CAG with intramuscular or intravenous acetazolamide 500 mg and 3 hours later by a single drop of pilocarpine. When the patient cannot be treated with systemic medication, it seems appropriate to substitute topical timolol for acetazolamide to reduce the IOP to a level where the sphincter starts to react and then give pilocarpine to open the occluded chamber angle.
